BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27618250)

  • 1. An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia.
    Stock W; Diouf B; Crews KR; Pei D; Cheng C; Laumann K; Mandrekar SJ; Luger S; Advani A; Stone RM; Larson RA; Evans WE
    Clin Pharmacol Ther; 2017 Mar; 101(3):391-395. PubMed ID: 27618250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.
    Gutierrez-Camino A; Martin-Guerrero I; Lopez-Lopez E; Echebarria-Barona A; Zabalza I; Ruiz I; Guerra-Merino I; Garcia-Orad A
    Pharmacogenet Genomics; 2016 Feb; 26(2):100-2. PubMed ID: 26618658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of common and rare genetic variants in CEP72 on vincristine-induced peripheral neuropathy in brain tumour patients.
    Klumpers MJ; Brand ACAM; Hakobjan M; Gattuso G; Schiavello E; Terenziani M; Massimino M; Gidding CEM; Guchelaar HJ; Te Loo DMWM; Coenen MJH
    Br J Clin Pharmacol; 2022 Jul; 88(7):3463-3473. PubMed ID: 35150001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study.
    Zgheib NK; Ghanem KM; Tamim H; Aridi C; Shahine R; Tarek N; Saab R; Abboud MR; El-Solh H; Muwakkit SA
    Pharmacogenet Genomics; 2018 Aug; 28(8):189-195. PubMed ID: 30119132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
    Sawaki A; Miyazaki K; Yamaguchi M; Takeuchi T; Kobayashi K; Imai H; Tawara I; Ono R; Nosaka T; Katayama N
    Int J Hematol; 2020 May; 111(5):686-691. PubMed ID: 31993939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.
    Wright GEB; Amstutz U; Drögemöller BI; Shih J; Rassekh SR; Hayden MR; Carleton BC; Ross CJD;
    Clin Pharmacol Ther; 2019 Feb; 105(2):402-410. PubMed ID: 29999516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pharmacogenomics of Vincristine-Induced Neuropathy: On Pins and Needles.
    Berg SL; Parsons DW
    JAMA Oncol; 2015 Oct; 1(7):975-6. PubMed ID: 26181361
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of CEP72 rs924607 TT Genotype with Vincristine-induced Peripheral Neuropathy Measured by Motor Nerve Conduction Studies.
    Kavčič M; Zečkanović A; Jazbec J; Debeljak M
    Klin Padiatr; 2020 Nov; 232(6):331-333. PubMed ID: 32877958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia.
    Martin-Guerrero I; Gutierrez-Camino A; Echebarria-Barona A; Astigarraga I; Garcia de Andoin N; Navajas A; Garcia-Orad A
    Pharmacogenomics J; 2019 Dec; 19(6):564-569. PubMed ID: 30723315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy.
    McLeod HL
    JAMA; 2015 Feb; 313(8):803-4. PubMed ID: 25710656
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
    Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
    Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia.
    Sims RP
    J Oncol Pharm Pract; 2016 Feb; 22(1):76-81. PubMed ID: 25305360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
    Moudgil SS; Riggs JE
    Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of CEP72 Gene May Predispose Patients to Hepatotoxicity.
    Pham R; Hoeft A; Roberts C; Hamby T; Maloy C; Ray A
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e634-e636. PubMed ID: 31343483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
    J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.
    Jain P; Gulati S; Seth R; Bakhshi S; Toteja GS; Pandey RM
    J Child Neurol; 2014 Jul; 29(7):932-7. PubMed ID: 23781018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study.
    Bosilkovska M; Ing Lorenzini K; Uppugunduri CR; Desmeules J; Daali Y; Escher M
    Clin Ther; 2016 Jan; 38(1):216-20. PubMed ID: 26565076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
    Baker SK; Lipson DM
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.